메뉴 건너뛰기




Volumn 90, Issue 4, 2010, Pages 425-426

Refractory chronic urticaria treated effectively with the protease inhibitors nafamostat mesilate and camostat mesilate

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; C REACTIVE PROTEIN; CAMOSTAT MESILATE; HISTAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NAFAMSTAT MESILATE; CAMOSTAT; GABEXATE; GUANIDINE DERIVATIVE; NAFAMSTAT; PROTEINASE INHIBITOR;

EID: 77954923315     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0869     Document Type: Letter
Times cited : (16)

References (13)
  • 1
    • 36148996924 scopus 로고    scopus 로고
    • Guidelines for evaluation and management of urticaria in adults and children
    • Grattan CE, Humphreys F. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157: 1116-1123.
    • (2007) Br J Dermatol , vol.157 , pp. 1116-1123
    • Grattan, C.E.1    Humphreys, F.2
  • 3
    • 43449123325 scopus 로고    scopus 로고
    • Therapeutic alternatives for chronic urticaria: An evidence-based review, part 1
    • Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008; 100: 403-411.
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 403-411
    • Morgan, M.1    Khan, D.A.2
  • 4
    • 45149086027 scopus 로고    scopus 로고
    • Therapeutic alternatives for chronic urticaria: An evidence-based review, part 2
    • Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol 2008; 100: 517-526. (Pubitemid 351829849)
    • (2008) Annals of Allergy, Asthma and Immunology , vol.100 , Issue.6 , pp. 517-526
    • Morgan, M.1    Khan, D.A.2
  • 5
    • 0017746348 scopus 로고
    • Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase
    • Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. Biochim Biophys Acta 1977; 484: 417-422.
    • (1977) Biochim Biophys Acta , vol.484 , pp. 417-422
    • Tamura, Y.1    Hirado, M.2    Okamura, K.3    Minato, Y.4    Fujii, S.5
  • 6
    • 0021265581 scopus 로고
    • Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments
    • Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, et al. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 1984; 35: 203-227.
    • (1984) Jpn J Pharmacol , vol.35 , pp. 203-227
    • Aoyama, T.1    Ino, Y.2    Ozeki, M.3    Oda, M.4    Sato, T.5    Koshiyama, Y.6
  • 7
    • 33745455885 scopus 로고    scopus 로고
    • Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma
    • Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, et al. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J Allergy Clin Immunol 2006; 118: 105-112.
    • (2006) J Allergy Clin Immunol , vol.118 , pp. 105-112
    • Chen, C.L.1    Wang, S.D.2    Zeng, Z.Y.3    Lin, K.J.4    Kao, S.T.5    Tani, T.6
  • 8
    • 0037353099 scopus 로고    scopus 로고
    • A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium
    • Sendo T, Itoh Y, Goromaru T, Sumimura T, Saito M, Aki K, et al. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol 2003; 138: 959-967.
    • (2003) Br J Pharmacol , vol.138 , pp. 959-967
    • Sendo, T.1    Itoh, Y.2    Goromaru, T.3    Sumimura, T.4    Saito, M.5    Aki, K.6
  • 9
  • 10
    • 0032839469 scopus 로고    scopus 로고
    • Complement dependence of histamine release in chronic urticaria
    • Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104: 169-172.
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 169-172
    • Ferrer, M.1    Nakazawa, K.2    Kaplan, A.P.3
  • 11
    • 0014458845 scopus 로고
    • Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema
    • Juhlin L, Michaelsson G. Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm Venereol 1969; 49: 37-44.
    • (1969) Acta Derm Venereol , vol.49 , pp. 37-44
    • Juhlin, L.1    Michaelsson, G.2
  • 12
    • 0016167068 scopus 로고
    • Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor
    • Berova N, Petkov I, Andreev VC. Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor. Br J Dermatol 1974; 90: 431-434.
    • (1974) Br J Dermatol , vol.90 , pp. 431-434
    • Berova, N.1    Petkov, I.2    Andreev, V.C.3
  • 13
    • 0142183301 scopus 로고    scopus 로고
    • Protease inhibitors in the treatment of hereditary angioedema
    • Ritchie BC. Protease inhibitors in the treatment of hereditary angioedema. Transfus Apher Sci 2003; 29: 259-267.
    • (2003) Transfus Apher Sci , vol.29 , pp. 259-267
    • Ritchie, B.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.